THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS
Methods of identification of loratadine in tablets by absorption spectrophotometry, TLC and qualitative reaction (based on hydroxamic reaction) have been developed and validated. The development of scientifically based standardized procedures for the validation of analytical methods for identific...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporozhye State Medical University
2015-04-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/24833/22318 |
| _version_ | 1818753482856857600 |
|---|---|
| author | D. B. Korobko O. B. Poliak L. S. Logoida N. O. Zarіvna O. V. Sem’ianіv |
| author_facet | D. B. Korobko O. B. Poliak L. S. Logoida N. O. Zarіvna O. V. Sem’ianіv |
| author_sort | D. B. Korobko |
| collection | DOAJ |
| description | Methods of identification of loratadine in tablets by absorption spectrophotometry, TLC and qualitative reaction (based on hydroxamic reaction) have been developed and validated.
The development of scientifically based standardized procedures for the validation of analytical methods for identification and quantitative tests of determination the active ingredients and other components in drugs is very important. The selected object of the study was loratadine (Claritin) – second generation antihistaminic drugs. According to the chemical structure loratadine is ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-ylidene)-1-piperidine carboxylate.
The purpose of our work is the development and validation of methods for identification of loratadine in tablets.
When developing methods of identification of loratadine in tablets we used UV-spectrophotometry and TLC. We have studied the behavior of loratadine in the UV region of the spectrum in different solvents (ethanol, 0.1 mol/l solution of hydrochloric acid). Optical density of solutions was measured at 2 nm in the cell with a thickness of10 mm. The behavior of loratadine in the UV region of spectrum in different solvents shows that in all investigated solvents drugs have characteristic absorption bands in the wavelength range at 220-310 nm. Thus different maximum absorptions of loratadine has been observed in various solvents: ethanol – at 248 ± 2 nm, in 0.1 mol/l hydrochloric acid solution there are two absorptions maxima – at 248 ± 2 nm and 274 ± 2 nm. UV spectra of loratadine in all investigated solvents are characterized by the same absorption maximum at 248 ± 2 nm, this makes possible to use UV-spectrophotometry for identification of loratadine in tablets.
We have investigated various mobile phases (solvent system) in order to identify the optimal choice of loratadine in tablets by TLC. For the purpose of methods for loratadine identification in other solvent systems, we have investigated the sensitivity detection of loratadine in them. Therefore, to identify loratadine in tablets TLC method can be used. It was established that the most optimal values of the coefficient of mobility are observed when using mobile phase: chloroform-acetone, 8:2. The detection limit for loratadine in the solvent system is 1.0 mg, which is not inferior to other mobile phases. According to the SPU and Notes of guidance on validation of analytical procedures: text and methodology (CPMP/ICH/381/95) for "Identification" must be validated to determine such characteristics as specificity and suitability of chromatographic system. When checking the stability of solution in time we used chromatography method in order to prepare fresh loratadine test solution and sustained test solution of loratadine. The solutions are stable over time, new areas have been identified. So, explored validation characteristics, namely specificity and suitability of the chromatographic system, meet the eligibility criteria established by the SPU. Also the known qualitative reaction for hydroxamic group with hydroxylamine and iron (III) chloride has been investigated and can be used to identify loratadine in tablets.
Conclusions
1. We proposed and developed UV-spectrophotometry methods, TLC and hydroxamic reaction to identify loratadine in tablets.
2. Validation characteristics, namely specificity and suitability of the chromatographic system have been studied. It has been established that they meet the eligibility criteria required by SPU. |
| first_indexed | 2024-12-18T05:08:04Z |
| format | Article |
| id | doaj.art-9b64758d74724ff09d12637579e3a90b |
| institution | Directory Open Access Journal |
| issn | 2306-8094 2409-2932 |
| language | English |
| last_indexed | 2024-12-18T05:08:04Z |
| publishDate | 2015-04-01 |
| publisher | Zaporozhye State Medical University |
| record_format | Article |
| series | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| spelling | doaj.art-9b64758d74724ff09d12637579e3a90b2022-12-21T21:19:57ZengZaporozhye State Medical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322015-04-011555810.14739/2409-2932.2014.1.24833THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETSD. B. KorobkoO. B. PoliakL. S. LogoidaN. O. ZarіvnaO. V. Sem’ianіvMethods of identification of loratadine in tablets by absorption spectrophotometry, TLC and qualitative reaction (based on hydroxamic reaction) have been developed and validated. The development of scientifically based standardized procedures for the validation of analytical methods for identification and quantitative tests of determination the active ingredients and other components in drugs is very important. The selected object of the study was loratadine (Claritin) – second generation antihistaminic drugs. According to the chemical structure loratadine is ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-ylidene)-1-piperidine carboxylate. The purpose of our work is the development and validation of methods for identification of loratadine in tablets. When developing methods of identification of loratadine in tablets we used UV-spectrophotometry and TLC. We have studied the behavior of loratadine in the UV region of the spectrum in different solvents (ethanol, 0.1 mol/l solution of hydrochloric acid). Optical density of solutions was measured at 2 nm in the cell with a thickness of10 mm. The behavior of loratadine in the UV region of spectrum in different solvents shows that in all investigated solvents drugs have characteristic absorption bands in the wavelength range at 220-310 nm. Thus different maximum absorptions of loratadine has been observed in various solvents: ethanol – at 248 ± 2 nm, in 0.1 mol/l hydrochloric acid solution there are two absorptions maxima – at 248 ± 2 nm and 274 ± 2 nm. UV spectra of loratadine in all investigated solvents are characterized by the same absorption maximum at 248 ± 2 nm, this makes possible to use UV-spectrophotometry for identification of loratadine in tablets. We have investigated various mobile phases (solvent system) in order to identify the optimal choice of loratadine in tablets by TLC. For the purpose of methods for loratadine identification in other solvent systems, we have investigated the sensitivity detection of loratadine in them. Therefore, to identify loratadine in tablets TLC method can be used. It was established that the most optimal values of the coefficient of mobility are observed when using mobile phase: chloroform-acetone, 8:2. The detection limit for loratadine in the solvent system is 1.0 mg, which is not inferior to other mobile phases. According to the SPU and Notes of guidance on validation of analytical procedures: text and methodology (CPMP/ICH/381/95) for "Identification" must be validated to determine such characteristics as specificity and suitability of chromatographic system. When checking the stability of solution in time we used chromatography method in order to prepare fresh loratadine test solution and sustained test solution of loratadine. The solutions are stable over time, new areas have been identified. So, explored validation characteristics, namely specificity and suitability of the chromatographic system, meet the eligibility criteria established by the SPU. Also the known qualitative reaction for hydroxamic group with hydroxylamine and iron (III) chloride has been investigated and can be used to identify loratadine in tablets. Conclusions 1. We proposed and developed UV-spectrophotometry methods, TLC and hydroxamic reaction to identify loratadine in tablets. 2. Validation characteristics, namely specificity and suitability of the chromatographic system have been studied. It has been established that they meet the eligibility criteria required by SPU.http://pharmed.zsmu.edu.ua/article/view/24833/22318identificationvalidationspectrophotometryTLHloratadinetablets |
| spellingShingle | D. B. Korobko O. B. Poliak L. S. Logoida N. O. Zarіvna O. V. Sem’ianіv THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki identification validation spectrophotometry TLH loratadine tablets |
| title | THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS |
| title_full | THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS |
| title_fullStr | THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS |
| title_full_unstemmed | THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS |
| title_short | THE DEVELOPMENT AND VALIDATION OF IDENTIFICATION METHODS OF LORATADINE TABLETS |
| title_sort | development and validation of identification methods of loratadine tablets |
| topic | identification validation spectrophotometry TLH loratadine tablets |
| url | http://pharmed.zsmu.edu.ua/article/view/24833/22318 |
| work_keys_str_mv | AT dbkorobko thedevelopmentandvalidationofidentificationmethodsofloratadinetablets AT obpoliak thedevelopmentandvalidationofidentificationmethodsofloratadinetablets AT lslogoida thedevelopmentandvalidationofidentificationmethodsofloratadinetablets AT nozarívna thedevelopmentandvalidationofidentificationmethodsofloratadinetablets AT ovsemianív thedevelopmentandvalidationofidentificationmethodsofloratadinetablets AT dbkorobko developmentandvalidationofidentificationmethodsofloratadinetablets AT obpoliak developmentandvalidationofidentificationmethodsofloratadinetablets AT lslogoida developmentandvalidationofidentificationmethodsofloratadinetablets AT nozarívna developmentandvalidationofidentificationmethodsofloratadinetablets AT ovsemianív developmentandvalidationofidentificationmethodsofloratadinetablets |